About six months after coming out of stealth with $50 million in funding, Latent Labs has released a web-based AI model for ...

About TX45, a long-acting Fc-relaxin fusion proteinTX45 is an Fc-relaxin fusion protein with optimized pharmacokinetics and biophysical properties that activates the RXFP1 receptor, the G-protein ...

An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin has ...

An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin ...

The team found that multiple injections of human relaxin directly into the afflicted joint restored range of motion and improved tissue health in an animal model of frozen shoulder, a painful and ...

Talking receptors may affect relaxin at work Date: September 11, 2019 Source: Monash University Summary: A research team investigating the promising anti-fibrotic effects of a drug version of the ...

Upcoming topline results from the ongoing TX45 clinical program includes Phase 1b hemodynamic, proof-of-concept trial data expected in late 1Q or early 2Q’2025, and APEX Phase 2 clinical trial ...